BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22289789)

  • 1. Serological assessment of gastric mucosal atrophy in gastric cancer.
    Bornschein J; Selgrad M; Wex T; Kuester D; Malfertheiner P
    BMC Gastroenterol; 2012 Jan; 12():10. PubMed ID: 22289789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.
    Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Mernova VP; Polyakova MB
    Scand J Gastroenterol; 2005 Mar; 40(3):297-301. PubMed ID: 15932170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
    Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes.
    Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Mernova VP; Polyakova MB
    World J Gastroenterol; 2004 Nov; 10(21):3146-50. PubMed ID: 15457561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.
    Hansen S; Vollset SE; Derakhshan MH; Fyfe V; Melby KK; Aase S; Jellum E; McColl KE
    Gut; 2007 Jul; 56(7):918-25. PubMed ID: 17317788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
    De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
    Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of biologic parameters in Helicobacter pylori gastritis: comparison with histological results].
    Abaza H; Ghanem A; Karoui J; Jmal A; Dhouib R; Harzallah L; Ben Mami N; Khaled R; Guemira F
    Ann Biol Clin (Paris); 2010; 68(4):473-9. PubMed ID: 20650743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Serological Gastric Biopsy in Different Gastric Mucosal Lesions: an Observational Study.
    Dong Z; Zhang X; Chen X; Zhang J
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31414587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics.
    Kato S; Matsukura N; Tsukada K; Matsuda N; Mizoshita T; Tsukamoto T; Tatematsu M; Sugisaki Y; Naito Z; Tajiri T
    Cancer Sci; 2007 Jun; 98(6):790-4. PubMed ID: 17470129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.
    Ono S; Kato M; Suzuki M; Ishigaki S; Takahashi M; Haneda M; Mabe K; Shimizu Y
    Digestion; 2012; 86(1):59-65. PubMed ID: 22722747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
    Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
    Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA.
    Ye W; Held M; Enroth H; Kraaz W; Engstrand L; Nyrén O
    Scand J Gastroenterol; 2005 Mar; 40(3):312-8. PubMed ID: 15932172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
    Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
    Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer.
    Kikuchi R; Abe Y; Iijima K; Koike T; Ara N; Uno K; Asanuma K; Asano N; Imatani A; Shimosegawa T
    Tohoku J Exp Med; 2011 Jan; 223(1):35-44. PubMed ID: 21222340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.